FIG. 1.
Changes in PI resistance profiles between the baseline and rebound in patients treated with a regimen containing DRV. IDV, indinavir; SQV, saquinavir; NFV, nelfinavir; APV, amprenavir; LPV, lopinavir; ATV, atazanavir; TPV, tipranavir.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.